Skip to content
HeyJared

Kathleen Doheny

Reporter · US

Indexed articles, last 90 days
11
Latest publication
Sep 28, 2026
Outlet visibility, for Medscape
Top 50K sites
Earliest in this view
Jul 14, 2026

Latest articles

  1. Article · Sep 28, 2026 · Kathleen Doheny

    Tai Chi May Ease Cancer-Related Fatigue and Pain (opens the original)

    Excerpt · English

    Read excerpt

    Tai chi and mindfulness practices may help patients with cancer get some relief from fatigue, pain, and sleep problems, a new clinical trial suggests. The study, of nearly 600 participants, found that both practices lessened fatigue and the impact of pain on daily life vs a waitlist control. Tai chi also boosted sleep quality to a small degree. The findings, published in the Journal of Clinical Oncology, come from a partially randomized trial — where participants were allowed to choose either ta

  2. Article · Sep 15, 2026 · Kathleen Doheny

    Food Tracking for Weight Loss: More Tracking, More Loss (opens the original)

    Excerpt · English

    Read excerpt

    Tracking food intake to lose weight is an age-old idea with a modern twist. Numerous smartphone apps, many with free features, can help users tally up exactly what has been gobbled down. And now, a new study finds that those who track consistently do lose more weight than the less conscientious trackers. The surprise? Even those who tracked less than daily lost weight. While food tracking draws praise from some, it provokes loud groans from others who complain they don’t have the time to deal wi

  3. Article · Sep 8, 2026 · Kathleen Doheny

    Shifting the Weight-Loss Focus: More Than Pounds Lost (opens the original)

    Excerpt · English

    Read excerpt

    Every new GLP-1 seems to promise a higher quantity of weight loss for adults with obesity, with the message of more pounds lost, more success. Tirzepatide (Zepbound) produced a 22.5% average reduction at 72 weeks, with the Obesity Medicine Association citing the SURMOUNT-1 trial and saying it stands out as “the most effective FDA-approved prescription medication for weigh loss.” On its heels, however, are other medications, including retatrutide, the triple agonist medication activating receptor

  4. Article · Sep 1, 2026 · Kathleen Doheny

    Remote CBT for Insomnia Improves Symptoms During Chemo (opens the original)

    Excerpt · English

    Read excerpt

    A behavioral intervention for insomnia, delivered remotely, can improve sleep quality among women undergoing chemotherapy for breast cancer, according to a new clinical trial. Bright light therapy, on the other hand, failed to live up to expectations. The trial found that patients who received 6 weeks of cognitive-behavioral therapy for insomnia (CBT-I) had a greater improvement in their sleep problems than those who did not receive the therapy. In contrast, bright light therapy — a strategy tha

  5. Article · Aug 25, 2026 · Kathleen Doheny

    Is There a ‘Best’ GLP-1 Injection Site? (opens the original)

    Excerpt · English

    Read excerpt

    The questions seem simple enough: Is there a best site on your body to inject a GLP-1 medication? Will one site provide better absorption, fewer side effects, or greater success than another? The short answer is no. But when the question is asked on social media, it prompts a torrent of responses and strong opinions, frequently from people with no medical background. Michelle E. Gordon, DO, an obesity medicine direct-pay physician in Westchester, New York, who frequently posts on social media, r

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 50K sites

For Medscape, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Kathleen Doheny